These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12546068)

  • 21. [Mutation analysis of transforming growth factor-beta type II receptor gene in human gastric cancer tissues].
    Ke Y; Hagiwara K; Su X
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):25-7. PubMed ID: 10743049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.
    Mitchell TJ; Whittaker SJ; John S
    Cancer Res; 2003 Dec; 63(24):9048-54. PubMed ID: 14695224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A miniature condition in Brahman cattle is associated with a single nucleotide mutation within the growth hormone gene.
    McCormack BL; Chase CC; Olson TA; Elsasser TH; Hammond AC; Welsh TH; Jiang H; Randel RD; Okamura CA; Lucy MC
    Domest Anim Endocrinol; 2009 Aug; 37(2):104-11. PubMed ID: 19524387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
    Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
    Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of antisense transforming growth factor beta receptor-II (TGFbetaRII) expressing plasmid on experimental liver fibrosis].
    Jiang W; Wang JY; Yang CQ; Liu WB; Wang YQ; He BM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):137-40. PubMed ID: 15059294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells.
    Rossi MR; Ionov Y; Bakin AV; Cowell JK
    Cancer Genet Cytogenet; 2005 Dec; 163(2):123-9. PubMed ID: 16337854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
    D'Abronzo FH; Swearingen B; Klibanski A; Alexander JM
    J Clin Endocrinol Metab; 1999 May; 84(5):1716-21. PubMed ID: 10323406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas.
    Woszczyk D; Gola J; Jurzak M; Mazurek U; Mykała-Cieśla J; Wilczok T
    Med Sci Monit; 2004 Jan; 10(1):CR33-7. PubMed ID: 14704634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
    Baugé C; Legendre F; Leclercq S; Elissalde JM; Pujol JP; Galéra P; Boumédiene K
    Arthritis Rheum; 2007 Sep; 56(9):3020-32. PubMed ID: 17763417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Birt-Hogg-Dubé (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.
    Jiang W; Fujii H; Matsumoto T; Ohtsuji N; Tsurumaru M; Hino O
    Cancer Lett; 2007 Apr; 248(1):103-11. PubMed ID: 16870330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations.
    Arjona D; Bello MJ; Alonso ME; Aminoso C; Isla A; De Campos JM; Sarasa JL; Gutierrez M; Villalobo A; Rey JA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):384-94. PubMed ID: 16008822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cells.
    Chen KL; Liu WH; Yang YY; Leu SJ; Shih NY
    BMC Mol Biol; 2007 Aug; 8():72. PubMed ID: 17705854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
    Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
    J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.